MMP2 and breast carcinoma: This is particularly true for breast cancer, as silencing of OPN not only inhibited cancer progression through downregulation of uPA, MMP-2, and MMP-9 expression levels [226] but also rendered these cells more sensitive to radiation-induced apoptosis and senescence [227] and enhanced their sensitivity to chemotherapeutic agents [228].